Whole Blood Point of Care Metabolic Measurement

父母补助金：HD107897

Parent Grant: HD107897 PA-21-345 Administrative Supplement for Long-Term Investigator Project Summary Sequitur Health Corp. is performing research for a National Institutes of Health Phase II Small Business Innovation Research (SBIR) Parent Grant: HD107897 to develop a point of care system for measurement of an analyte directly from a drop of whole blood. The Sequitur system has >90% accuracy for measurement of this analyte compared to the U.S. Food and Drug Administration approved clinical laboratory instrument method for measuring this analyte. Sequitur Health Corp. is a women-owned small business that is partially owned by a female from a socially disadvantaged group, as defined by the United States Small Business Association (U.S. SBA). Sequitur will use this supplement to hire a Ph.D.-level Hispanic female, who is from a socially disadvantaged group as defined by the U.S. SBA. This Long-Term Investigator will contribute to the completion of the parent Phase II SBIR award ongoing research Aims. The immediate impact of this administrative supplement will be to increase diversity in the United States Small Business workforce. The long-term impact of this administrative supplement will be to help the individual hired contribute to the ongoing research, develop more skills, and launch a successful career as an entrepreneurial-minded independent scientist.